Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

324
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
324
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

682
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
682
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intelligent Virtual Dental Implant Placement via 3D Segmentation Strategy.

Journal of dental research·2025
Same author

Intracranial hypertension in a child with abusive head trauma.

Journal francais d'ophtalmologie·2023
Same author

[Efficacy of intravenous drug information management system on the improvement of anemia in maintenance hemodialysis patients].

Zhonghua yi xue za zhi·2023
Same author

Observation of Three Charmoniumlike States with J^{PC}=1^{--} in e^{+}e^{-}→D^{*0}D^{*-}π^{+}.

Physical review letters·2023
Same author

Evidence for the Cusp Effect in η' Decays into ηπ^{0}π^{0}.

Physical review letters·2023
Same author

Sex and pubertal influences on the neurodevelopmental underpinnings of schizophrenia: A case for longitudinal research on adolescents.

Schizophrenia research·2023

Related Experiment Video

Updated: Mar 15, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

15.3K

Hyperlipidemia impairs erectile function in rats by causing cavernosal fibrosis.

R Li1,2, K Cui1,2, T Wang1,2

  • 1Department of Urology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Andrologia
|September 14, 2016
PubMed
Summary

Hyperlipidemia, a condition of high cholesterol, is linked to erectile dysfunction (ED) in men. This study in rats suggests hyperlipidemia causes ED by increasing penile fibrosis and apoptosis.

Keywords:
apoptosisautophagyerectile dysfunctionfibrosishyperlipidemia

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.2K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

2.0K

Related Experiment Videos

Last Updated: Mar 15, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

15.3K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.2K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

2.0K

Area of Science:

  • Urology
  • Endocrinology
  • Cardiovascular Research

Background:

  • Hyperlipidemia is a known risk factor for erectile dysfunction (ED).
  • The precise mechanisms linking hyperlipidemia to ED remain unclear.
  • Understanding these mechanisms is crucial for developing targeted treatments.

Purpose of the Study:

  • To investigate the underlying mechanisms of ED in rats induced by hyperlipidemia.
  • To evaluate the impact of hyperlipidemia on penile tissue structure and function.
  • To explore the roles of apoptosis, autophagy, and fibrosis in hyperlipidemia-associated ED.

Main Methods:

  • Rats were fed a high-cholesterol diet for six months to induce hyperlipidemia.
  • Erectile function was assessed via cavernous nerve electrostimulation and intracavernosal pressure measurements.
  • Penile tissues were analyzed for apoptosis (TUNEL assay), autophagy, fibrosis, and smooth muscle/collagen ratio using immunohistochemistry and Western blotting.

Main Results:

  • Hyperlipidemic rats showed significantly elevated plasma lipid levels compared to controls.
  • Erectile function was markedly reduced in the hyperlipidemia group.
  • Penile tissues exhibited increased fibrosis, elevated apoptosis, decreased autophagy, and a lower smooth muscle/collagen ratio.

Conclusions:

  • Hyperlipidemia significantly impairs erectile function in rats.
  • The mechanism involves increased cavernosal fibrosis and apoptosis in penile tissue.
  • These findings highlight fibrosis as a key factor in hyperlipidemia-induced ED.